Covered recipient · General Payments record
RIZWANUDDIN M FAROOQI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,735.50
- Reported across 283 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $690.17 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $283.52 | 13 |
| PFIZER INC. | $84.13 | 4 |
| DEXCOM, INC. | $77.87 | 4 |
| GlaxoSmithKline, LLC. | $70.79 | 4 |
| ABBVIE INC. | $55.70 | 4 |
| Lilly USA, LLC | $54.92 | 3 |
| Currax Pharmaceuticals LLC | $34.02 | 2 |
| Lucid Diagnostics Inc. | $15.57 | 1 |
| Amgen Inc. | $13.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.87 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103712433 | CMS |
| ABBVIE INC. | $14.68 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103712435 | CMS |
| ABBVIE INC. | $13.97 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103712437 | CMS |
| ABBVIE INC. | $13.18 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103712439 | CMS |
| Amgen Inc. | $13.65 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117551577 | CMS |
| Currax Pharmaceuticals LLC | $16.87 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089514954 | CMS |
| Currax Pharmaceuticals LLC | $17.15 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089514956 | CMS |
| Dexcom, Inc. | $14.21 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153331175 | CMS |
| Dexcom, Inc. | $17.39 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153331177 | CMS |
| Dexcom, Inc. | $32.32 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153331179 | CMS |
| Dexcom, Inc. | $13.95 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153331181 | CMS |
| GlaxoSmithKline, LLC. | $15.35 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116400318 | CMS |
| GlaxoSmithKline, LLC. | $15.15 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115944650 | CMS |
| GlaxoSmithKline, LLC. | $14.80 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116285282 | CMS |
| GlaxoSmithKline, LLC. | $25.49 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116641022 | CMS |
| Lilly USA, LLC | $17.33 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135366914 | CMS |
| Lilly USA, LLC | $21.44 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135358432 | CMS |
| Lilly USA, LLC | $16.15 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135335573 | CMS |
| Lucid Diagnostics Inc. | $15.57 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152301238 | CMS |
| Novo Nordisk Inc | $22.65 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096898555 | CMS |
| Novo Nordisk Inc | $19.69 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096900939 | CMS |
| Novo Nordisk Inc | $22.96 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097763499 | CMS |
| Novo Nordisk Inc | $24.60 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097483860 | CMS |
| Novo Nordisk Inc | $15.22 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096670808 | CMS |
| Novo Nordisk Inc | $24.74 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097825163 | CMS |
| Novo Nordisk Inc | $15.75 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097067414 | CMS |
| Novo Nordisk Inc | $23.19 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096712948 | CMS |
| Novo Nordisk Inc | $18.37 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097058362 | CMS |
| Novo Nordisk Inc | $25.49 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097195958 | CMS |
| Novo Nordisk Inc | $18.93 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096829044 | CMS |
| Novo Nordisk Inc | $19.88 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097811052 | CMS |
| Novo Nordisk Inc | $32.05 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097654790 | CMS |
| PFIZER INC. | $18.13 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131479921 | CMS |
| PFIZER INC. | $24.02 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131749682 | CMS |
| PFIZER INC. | $17.06 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131847493 | CMS |
| PFIZER INC. | $24.92 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131961448 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.